Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development

por Sung, Yun-Chieh, Liu, Ya-Chi, Chao, Po-Han, Chang, Chih-Chun, Jin, Pei-Ru, Lin, Ts-Ting, Lin, Ja-An, Cheng, Hui-Teng, Wang, Jane, Lai, Charles P., Chen, Ling-Hsuan, Wu, Anthony Y., Ho, Ting-Lun, Chiang, Tsaiyu, Gao, Dong-Yu, Duda, Dan G., Chen, Yunching
Publicado 2018